Mumbai, 6 March 2024: Cipla Limited has received approval from the Central Drugs Standard Control Organization (CDSCO) to market the novel antibiotic plazomicin in India.

Plazomicin is a new intravenous (IV) aminoglycoside indicated for the treatment of complicated uri......
View Details

Related News

• NPPA asks retailers, dealers and online pharmacies to ensure compliance of Para 24 and 25 of DPCO, 2013 (11-02-2025)

---

• Kerala: 12 establishments caught selling fake cosmetics, including soaps and creams, with harmful chemicals (11-02-2025)

---

• EMA establishes regular procedure for scientific advice on certain high-risk medical devices (11-02-2025)

---

• Goyal urges the pharmaceutical industry to expose those engaged in sale of counterfeit products (11-02-2025)

---

• WHO identifies research priorities for boosting fight against antimicrobial resistance (11-02-2025)

---

• Supreme Court Calls on State Officials to Address Misleading Drug Advertisements (10-02-2025)

---

• Cases will be initiated immediately against individuals involved in sale of intoxicants and adulteration of drugs (10-02-2025)

---

• An index to gauge states for drug enforcement, improve drug quality (10-02-2025)

---

• China's health regulator defends quality of local generic drugs (10-02-2025)

---

• DGFT amends standard input output norms for erythromycin stearate tablets (10-02-2025)

---